Mr Larry Alan Johnson, OT,CHT | |
8421 E 61st St, Suite P, Tulsa, OK 74133-1924 | |
(918) 459-9305 | |
(918) 250-6032 |
Full Name | Mr Larry Alan Johnson |
---|---|
Gender | Male |
Speciality | Occupational Therapist - Hand |
Location | 8421 E 61st St, Tulsa, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093860967 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225XH1200X | Occupational Therapist - Hand | 003049 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Larry Alan Johnson, OT,CHT 8421 E 61st St, Suite P, Tulsa, OK 74133-1924 Ph: (918) 459-9305 | Mr Larry Alan Johnson, OT,CHT 8421 E 61st St, Suite P, Tulsa, OK 74133-1924 Ph: (918) 459-9305 |
News Archive
Patients with prostate, bladder or kidney cancers are at greater risk of dying if they have had psychiatric care prior to the cancer treatment. In addition, patients with these cancers show greater suicide risk than the general population, even once the data is corrected for previous psychiatric care.
Taking the first deep dive into how the immune system is behaving in patients with multisystem inflammatory syndrome in children (MIS-C), researchers at Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania have found that children with this condition have highly activated immune systems that, in many ways, are more similar to those of adults with severe COVID-19.
Scientists working on a new tuberculosis vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with a technique developed at the University of Bath.
TheraQuest Biosciences, Inc. a development stage pain management company today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug ("IND") application for TQ-1015, its abuse deterrent extended release strong opioid. TQ-1015 is being developed using Securel, TheraQuest's proprietary abuse deterrent technology.
Nature, through the trial and error of evolution, has discovered a vast diversity of life from what can only presumed to have been a primordial pool of building blocks.
› Verified 6 days ago
Ms. Talitha Gloria Glosemeyer, OT/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6127 S Joplin Ave, Tulsa, OK 74136 Phone: 405-503-6825 | |
Amy M Buck, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 12697 E 51st St, Tulsa, OK 74146 Phone: 918-505-3200 | |
Kylah Clovis, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5110 S Yale Ave Ste 102, Tulsa, OK 74135 Phone: 918-492-2386 Fax: 918-645-8686 | |
Piper Rinehart, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7608 E 91st St, Tulsa, OK 74133 Phone: 918-663-0606 Fax: 918-663-8754 | |
Mrs. Summer Trook, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1724 S Harvard Ave, Tulsa, OK 74112 Phone: 918-250-7093 Fax: 918-250-9976 | |
Mrs. Rose Marie Martino, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1145 S Utica Ave, Suite 262, Tulsa, OK 74104 Phone: 918-579-3035 Fax: 918-579-3299 | |
Kristina Sowards, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4129 S Trenton Ave, Tulsa, OK 74105 Phone: 918-361-9722 |